Brooke Inez Ellingson Eischens, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 968 Grand Ave, Saint Paul, MN 55105 Phone: 651-895-2520 |
Madeline Gardner, APRN CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 624 Smith Ave S, Saint Paul, MN 55107 Phone: 651-689-3988 |
Brittany Morgan Jerez, DNP, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 968 Grand Ave, Saint Paul, MN 55105 Phone: 651-895-2520 Fax: 651-330-3768 |
Leslie Faith Morrison, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 555 Cedar St, Saint Paul, MN 55101 Phone: 651-266-1255 |
Antionette Renee Estis, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 153 Cesar Chavez St, Saint Paul, MN 55107 Phone: 651-602-7500 |
Ms. Aszani Stoddard, APRN, CNM, MSN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1619 Dayton Ave Ste 109, Saint Paul, MN 55104 Phone: 651-237-9665 Fax: 612-392-0118 |
Meghan Jessica Hohenstein, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 205 Wabasha St S, Saint Paul, MN 55107 Phone: 952-967-5584 |
Melinda Denson, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 153 Cesar Chavez St, Saint Paul, MN 55107 Phone: 651-602-7500 |
Karin E Marshall, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 205 Wabasha St S, Saint Paul, MN 55107 Phone: 651-293-8100 Fax: 651-293-8106 |
Erin Galegher, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 205 Wabasha St S, Saint Paul, MN 55107 Phone: 651-293-8100 |
News Archive
A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the six months ended June 30, 2015 and updates on its drug development programs.
The US house of Representatives has voted narrowly to pass a landmark reform that has been on the agenda for quite some time now. The bill passed by 219 votes to 212, with no Republican backing after strong debate. This bill will extend insurance coverage to 32 million more Americans, and marks the biggest change to the US healthcare system in decades.
Omeros Corporation today announced that its Investigational New Drug Application (IND) to evaluate OMS721 for the inhibition of complement‑mediated thrombotic microangiopathies (TMAs) has been cleared by the U.S. Food and Drug Administration.
› Verified 3 days ago